Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the ...

Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...

Demonstrators gathered outside Google DeepMind's London office on Monday to accuse the company of reneging on a key AI ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Now Google’s DeepMind division says it’s made a leap in trying to understand the code with AlphaGenome, an AI model that ...

The new Gemini Robotics On-Device AI allows robots to perform complex tasks without internet, offering enhanced privacy, ...

DeepMind's new AI system gives robots an inner voice, enabling zero-shot learning and efficient task mastery without prior ...

Google DeepMind is rolling out an on-device version of its Gemini Robotics AI model that allows it to operate without an ...

Hassabis co-founded DeepMind in 2010 with Shane Legg and Mustafa Suleyman, and Google acquired the company for $500 million in 2014. The lab would go on to make headlines numerous times in the ...